NRSN — Neurosense Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapMomentum Trap

Annual balance sheet for Neurosense Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	R2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	20-F	20-F	6-K
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	0.895	0.699	11.1	7.09	2.64
Net Total Receivables	0.018	0.03	0.178	0.131	0.236
Prepaid Expenses
Total Other Current Assets
Total Current Assets	0.913	0.729	11.4	7.38	2.92
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.007	0.013	0.019	0.306	0.247
Other Long Term Assets
Total Assets	0.955	0.779	11.4	7.71	3.19
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	0.037	0.12	0.597	1.73	3.46
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	0.037	0.12	2.42	2.09	4.94
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	0.918	0.659	9.01	5.62	-1.76
Total Liabilities & Shareholders' Equity	0.955	0.779	11.4	7.71	3.19
Total Common Shares Outstanding